Cephalon Slams Bid To Reinstate Pa. Opioid Marketing Suit
By Matt Fair ( October 3, 2017, 4:33 PM EDT) -- A Pennsylvania appeals court was urged on Monday to affirm a decision that federal law preempted claims that off-label marketing by Cephalon Inc. of its opioid painkiller "lollipop" Actiq to treat migraines had led to the death of a Philadelphia family's adult son....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.